JW CAYMAN THERAPEUTICS CO LTD. earnings per share and revenue

JWCTF earnings per share for the last semiannual are -0.08 USD whereas the estimation was -0.09 USD which accounts for 9.38% surprise. Company revenue for the same period amounts to 11.94 M USD despite the estimated figure of 14.82 M USD. Estimated earnings per share for the next semiannual are -0.09 USD, and revenue is expected to reach 18.19 M USD. Also watch annual changes over time to get a bigger picture of JWCTF earnings per share and revenue dynamics.